Göknur YAVUZ ÖZAYDIN
(Sivas Numune Hastanesi, Dermatoloji Kliniği, Sivas, Türkiye)
İbrahim Halil YAVUZ
(Yüzüncü Yıl Üniversitesi, Tıp Fakültesi, Dermatoloji Anabilim Dalı, Van, Türkiye)
Yıl: 2014Cilt: 21Sayı: 4ISSN: 1300-2694 / 2587-0351Sayfa Aralığı: 259 - 268Türkçe

169 2
Melanositik Nevusler
Melanositik nevus (mole), pigment üreten melanosit isimli hücrelerden oluşan benign poliferasyon/hamartom'dur. Melanositik nevuslar genellikle konjenital ve edinsel olarak iki gruba ayrılır. Konjenital nevuslar doğumda veya yaşamın ilk bir yılı içinde görülür, boyutları birkaç milimetreden vücut yüzeyinin büyük kısmını kaplayabilecek büyüklükte olabilir. Benign melanositik nevuslar koyu tenli bireylerde açık ve sarı tenli bireylere göre daha az sayıda görülür. Genelde benign nevuslar; küçük (6 milimetreden az), simetrik ve iyi konumlanmıştır. Bu derlemede melanositik nevüslerin sınıflandırılması, klinik özellikleri, tanısı, histopatolojisi ve tedavisi tartışılmıştır
Fen > Tıp > Cerrahi
DergiDerlemeErişime Açık
  • Burgdorf W.H.C, Plewig G, Wolff H.H. Landthaler M. Braun-Falco´s Dermatology 3rd ed, 2009. Springer Verlag; 1403-1413.
  • Tüzün Y, Gürer MA, Serdaroğlu S, Oğuz O, Aksungur LV. Deri tümörleri. Dermatoloji kitabı. Nobel tıp kitapevi. 3 baskı İstanbul 2008; 2: 1759-1962.
  • Elder David E, Elenitsas R.J, Bernett L. Murphy G.F. Lever's Histopathology of the Skin, 9th Edition. Lippincott Williams & Wilkins, 2005; 28.
  • Wolff K, Lowell A. Goldsmith, Stephen I. Katz, Barbara A. Gilchrest, Amy S. Paller, David J. Leffell. Fitzpatrick's Dermatology In General Medicine 7e. The McGraw-Hill Companies 2008: 122; 1137-1196.
  • Oğuz Oya. Melanosit hastalıkları, Pediatrik Dermatoloji Kitabı; Nobel Kitapevi. İstanbul 2005: 305-317.
  • Aydemir HE. Anderw's deri hastalıkları. Klinik Dermatoloji. Melanositik nevuslar ve neoplazmlar. Çeviri kitabı. İstanbul medikal yayıncılık onuncu baskı 2008; 685-701.
  • Enta T, Kwan TY. Melanocytic nevi in sun- protected Canadian Hutterite children. Arch Dermatol 1998; 134(3):379-381.
  • Gill M, Celebi JT. B-RAF and melanocytic neoplasia. J Am Acad Dermatol 2005; 53(1):108-114.
  • Peyssonnaux C, Eychène A. The Raf/MEK/ERK pathway: new concepts of activation. Biol Cell 2001; 93(1-2):53-62.
  • Pfahlberg A, Kölmel KF, Gefeller O. Febim Study Group. Timing of excessive ultraviolet radiation and melanoma: epidemiology does not support the existence of a critical period of high susceptibility to solar ultraviolet radiation- induced melanoma. Br J Dermatol 2001;
  • Coleman WP 3rd, Gately LE 3rd, Krementz AB, Reed RJ, Krementz ET. Nevi, lentigines, and melanomas in blacks. Arch Dermatol 1980; 116(5):548-551.
  • Schaffer JV, Bolognia JL. The biology of melanocytic nevi. In: Nordlund JJ, Boissy RE, Hearing VJ, et al. (eds). The Pigmentary System: Physiology and Pathophysiology, 2nd edn. Oxford: Blackwell Publishing 2006; 1092-125.
  • Banky JP, Kelly JW, English DR, Yeatman JM, Dowling JP. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma. Arch Dermatol 2005; 141(8):998- 1006.
  • Fitzpatrick TB. " Melanocytic nevi." Chapter in: Fitzpatrick's Dermatology in General Medicine, 5th Edn. Ed: I.M. Freedberg, et al. McGraw-Hill 1999; pages 1713-1740.
  • Weedon D. Tumors of cutaneous appendages. In: Weedon D. Weedon's Skin Pathology. 3rd ed. Oxford, United Kingdom: Churchill Livingstone 2010: 710-756.
  • Mackie RM. Melanocytic naevi and malignant melanoma. in: Champion RN, Burton JL, Burns DA, Breathnach M textbook of dermatology. 6 edition. london, blackwell science 1998:1717- 1752.
  • Agero AL, Benvenuto-Andrade C, Dusza SW, Halpern AC, Marghoob AA. Asymptomatic neurocutaneous melanocytosis in patients with large congenital melanocytic nevi: a study of cases from an Internet-based registry. J Am Acad Dermatol 2005; 53(6):959-965.
  • Tüzün Y, Kotogyan A, Serdaroğlu S, Çokuğras H, Tüzün B, Mat M.C. Melanosit hastalıkları ve pigmentasyon bozuklukları. Pediyatrik Dermatoloji, 1. Baskı 2005; 305-317.
  • Habif TP. Nevi and malignant melanoma. Clinical Dermatology: A Color Guide To Diagnosis And Therapy, 3 Edition, Mosby-Year Book 1999; 688-720.
  • DeCoste SD, Stern RS. Diagnosis and treatment of nevomelanocytic lesions of the skin. A community-based study. Arch Dermatol 1993; 129(1):57-62.
  • Burns T, Christopher G, Stephen B, Neil Cox. Rook's Textbook of Dermatology. 7st edition Wiley-Blackwell 2004; 38: 1-39.
  • Bastian BC, Olshen AB, LeBoit PE, Pinkel D. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol 2003; 163(5):1765-1770.
  • Zalaudek I ,Longo C , Ricci C ,Albertini G, and Argenziano G. Classifying Melanocytic Nevi : Nevogenesis, Marghoob (ed.), Springer-Verlag Berlin Heidelberg 2012;25-41.
  • Tucker MA, Halpern A, Holly EA, Hartge P, Elder DE, Sagebiel RW, et al. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA 1997; 277(18):1439-1444.
  • Tsao H, Bevona C, Goggins W, Quinn T. The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based estimate. Arch Dermatol 2003; 139(3):282-288.
  • Hoang MP, Prieto VG, Burchette JL, Shea CR. Recurrent melanocytic nevus: a histologic and immunohistochemical evaluation. J Cutan Pathol 2001; 28(8):400-406.
  • Sarıcaoğlu H. Bülbül Başkan E. Bolognıa Dermatoloji Türkçe Çeviri Kitabı. Nobel Tıp Kitabevi 2012: 1713-1740.
  • Clemmensen OJ, Kroon S. The histology of "congenital features" in early acquired melanocytic nevi. J Am Acad Dermatol 1988; 19(4):742-746.
  • Kinsler VA, Abu-Amero S, Budd P, Jackson IJ, Ring SM, Northstone K, et al. Germline melanocortin-1-receptor genotype is associated with severity of cutaneous phenotype in congenital melanocytic nevi: a role for MC1R in human fetal development. J Invest Dermatol 2012; 132(8):2026-2032.
  • Agero AL, Benvenuto-Andrade C, Dusza SW, Halpern AC, Marghoob AA. Asymptomatic neurocutaneous melanocytosis in patients with large congenital melanocytic nevi: a study of cases from an Internet-based registry. J Am Acad Dermatol 2005; 53(6):959-965.
  • Lyon VB. Congenital melanocytic nevi. Pediatr Clin North Am 2010; 57(5):1155-1176.
  • Huynh PM, Lazova R, Bolognia JL. Unusual halo nevi--darkening rather than lightening of the central nevus. Dermatology 2001; 202(4):324-327.
  • Zeff RA, Freitag A, Grin CM, Grant-Kels JM. The immune response in halo nevi. J Am Acad Dermatol 1997; 37(4):620-624.
  • Mooney MA, Barr RJ, Buxton MG. Halo nevus or halo phenomenon? A study of 142 cases. J Cutan Pathol 1995; 22(4):342-348.
  • Spatz A, Barnhill RL. The Spitz tumor 50 years later: revisiting a landmark contribution and unresolved controversy. J Am Acad Dermatol 1999; 40(2 Pt 1):223-228.
  • Bastian BC, Wesselmann U, Pinkel D, Leboit PE. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol 1999; 113(6):1065-1069.
  • Wick MR. Melanocytic lesions with features of Spitz nevus. Hum Pathol 2006; 37(7):779-780.
  • Evans SE, Gündüz Ö, Erkin G, Boztepe G, Şahin S, Özkaya Ö, Spitz Nevus'ün Klinik, Dermatoskopik ve Histopatolojik Özellikleri. Turkish Journal of Dermatology 2008; 2: 93-8.
  • Wei-Yu Lai, Chien-Ping Chiang, Tsai-Guang Chao. Ballon Ceel Nevus. J Med Sci 2004;
  • Demirhan B, Güleç T, Bilezikçi B, Celasun B. Yüzeysel nevus eksizyonundan sonra gelişen psödomelanom: Olgu sunumu, literatürün gözden geçirilmesi. Türk Patoloji Dergisi 2007; 23:169-172.
  • Cook MG. Benign melanocytic lesions mimicking melanomas. Pathology 2004; 36(5):414-418.
  • Özdemir F, Ceylan C, Ertam İ. Bölgemizde görülen Clark nevuslerin dermoskopik klasifikasyonu. Turkderm 2001; 35:300-306.
  • Wetherington RW, Cockerell CJ. The "dysplastic" nevus: an update at 25 years. Adv Dermatol 2003; 19:237-248.
  • Goldstein AM, Tucker MA, Crutcher WA, Hartge P, Sagebiel RW. The inheritance pattern of dysplastic naevi in families of dysplastic naevus patients. Melanoma Res 1993; 3(1):15- 22.
  • Matsumura Y, Nishigori C, Miyachi Y. Analysis of the p16 gene status of non-familial dysplastic nevus syndrome patients. Arch Dermatol Res 2001; 293(10):540-542.
  • Goldstein AM, Martinez M, Tucker MA, Demenais F. Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families. Cancer Epidemiol Biomarkers Prev 2000; 9(9):889-894.
  • Turner DJ, Zirvi MA, Barany F, Elenitsas R, Seykora J. Detection of the BRAF V600E mutation in melanocytic lesions using the ligase detection reaction. J Cutan Pathol 2005; 32(5):334-339.
  • Fears TR, Bird CC, Guerry D 4th, Sagebiel RW, Gail MH, Elder DE, et al. Average midrange ultraviolet radiation flux and time outdoors predict melanoma risk. Cancer Res 2002; 62(14):3992-3996.
  • Zalaudek I, Hofmann-Wellenhof R, Cerroni L, Kerl H. White dysplastic melanocytic naevi. Lancet 2002; 359(9322):1999-2000.
  • Tripp JM, Kopf AW, Marghoob AA, Bart RS. Management of dysplastic nevi: a survey of fellows of the American Academy of Dermatology. J Am Acad Dermatol 2002; 46(5):674-682.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.